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(Above) Average particle sizes for suspensions of the studied compounds in a variety of solvents. Samples
were tested at day 0 and day 14 or 21 after being kept between 2˚C-8˚C to determine changes in particle size
over time. Sizes under 200 nm are desirable as this allows for sterile filtration; the majority of compounds
resulted in a formulation with initial particle sizes below 200 nm.
(Below) Uniformity of the above particle sizes based upon polydispersity index (PDI.) PDI can be used to
determine the uniformity of particle sizes as well as the accuracy of the above particle sizes. A PDI below 0.2
suggests good uniformity of particles in the sample and reliability of the measured particle size.
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Mycobacterium tuberculosis (Mtb), the causative pathogen of tuberculosis
(TB), is a global threat. Tuberculosis remains one of the top ten causes of
death, with 10 million people affected by infections in 2017, resulting in
1.6 million deaths.
Adjuvants are substances used in the creation of vaccines which boost
immune response to an antigen, enhancing immune protection.
• Recent evidence suggests a T-helper cell 17 (Th17) response, part of the
body’s adaptive immune system, may protect against TB, but no Th17
adjuvants are clinically approved at this time.
• C-type lectin receptors (CLRs), such as Mincle, are a class of cellular
immunostimulatory receptor which have shown promise in driving a
Th17 response when stimulated by another molecule.
• Trehalose 6,6’-dimycolate (TDM) is the main immunostimulatory
component of the Mtb cell wall and a potent Mincle stimulator.
• TDM is too toxic to be used in a vaccine, but may lead to discovery of a
drug with low toxicity which can create a strong enough Th17 response
necessary to protect against TB.
In this study, immune responses were tested for an array of CLR-binding
adjuvant formulations in order to identify lead CLR adjuvant candidates for
use in next-generation TB vaccines.
Developing a Next-Generation TB Vaccine
Methods
A
B
(Above, Right: A, B) An example of the dispersions prepared via traditional bath
sonication shows settling and aggregation of particles, while (Above, Right: B) the
same dispersion prepared via focused ultra-sonication resulted in a uniform suspension.
Target Characteristics vs. Experimental Results
 Stable or easy to resuspend.
 Size less than 200 nm to allow sterile-
filtration.
 Increased immune response compared
to compounds in dimethyl sulfoxide
(DMSO.)
 High adsorption of antigen to particles.
 Isotonicity close to that of human blood.
 Explore effects of different diluents.
 Size was fairly stable in most samples,
however some samples grew from nano
to micron size.
 Initial particle size of the majority of
formulations were below 200 nm.
 Immunogenicity was increased in the
majority of nanodispersions when
compared to the same compound in
DMSO.
A method for determining antigen
adsorption remains in development.
 Isotonicity of samples was close to that
of blood in glycerol solution, but lower
when in water.
Water and glycerol samples showed
increased immune response over the
organic cocktail with water generally
resulting in easier formulatability.
Formulations Remain Relatively Stable Over Time
(Above) A HPLC method developed to determine concentration of the compounds used in this study. Results
showed 100% recovery with most compounds, the lowest observed value being 87%. The above method
worked universally for the studied compounds and allows for determination of LogP for future studies.
Determination of LogP allows for greater accuracy in determining the best solvent to use for a formulation.
Mobile Phase Method
Time 
(min) %A %B %C
Flow 
(mL/min) 
0 50 30 20
1 50 30 20
5 0 10 90 0.6
7 0 10 90
8 50 30 20
12 50 30 20
A: 0.1% TFA
B: 0.1% TFA, in methanol
C: Isopropanol
Improved Response Over Compounds in DMSO
Conclusions
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(Left) A representation of the structure of
trehalose 6,6’-dimycolate (TDM.)
(Right) Compounds used in these
experiments are trehalose diesters based
upon the structure of TDM.
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Concentrations and a Tool For Future Development
Future Directions
• Determine antigen adsorption to the particles in the dispersions.
• Add stabilizers to these formulations to increase size stability over time.
• Explore the effects of formulation macromolecular structure on immune response.
(Below) A diagram showing the method used 
to focus sonic energy in order to produce the 
studied samples.
Compound Structures
• Use of focused ultrasonication can produce smaller and more uniform particles than
traditional bath sonication.
• Using aqueous glycerol solution as the solvent results in favorable characteristics for
dispersions of the studied compounds when paired with focused ultrasonication.
• In vitro data suggests these dispersions can stimulate a strong immune response in
human cells, which is dependent upon both size and molecular structure.
Molecules similar to TDM are amphiphilic in nature, meaning they are
attracted to both water and fats, and can self-assemble in water to form
different sized particles. A technique utilizing focused ultrasonic energy
was used to prepare water-based dispersions of the studied compounds.
These aqueous formulations were characterized via a variety of analytical
methods including: dynamic light scattering (DLS), transmission electron
cryomicroscopy, high-performance liquid chromatography (HPLC), and
osmometry before in vitro, human cellular culture, tests were performed.
